151 related articles for article (PubMed ID: 2247631)
1. Total body irradiation and high-dose melphalan with bone marrow transplantation at Istituto Nazionale Tumori, Milan, Italy.
Gandola L; Lombardi F; Siena S; Bregni M; Piotti P; Sverzellati E; Stucchi C; Bonadonna G; Gianni AM; Lattuada A
Radiother Oncol; 1990; 18 Suppl 1():105-9. PubMed ID: 2247631
[TBL] [Abstract][Full Text] [Related]
2. Prospective evaluation of pulmonary function in cancer patients treated with total body irradiation, high-dose melphalan, and autologous hematopoietic stem cell transplantation.
Gandola L; Siena S; Bregni M; Sverzellati E; Piotti P; Stucchi C; Gianni AM; Lombardi F
Int J Radiat Oncol Biol Phys; 1990 Sep; 19(3):743-9. PubMed ID: 1976614
[TBL] [Abstract][Full Text] [Related]
3. Is veno-occlusive disease incidence influenced by the total-body irradiation technique?
Belkacémi Y; Ozsahin M; Rio B; Laporte JP; Leblond V; Pène F; Laugier A
Strahlenther Onkol; 1995 Dec; 171(12):694-7. PubMed ID: 8545791
[TBL] [Abstract][Full Text] [Related]
4. Technique, dosimetry and results of total body irradiation in preparation to ABMT in Torino.
Urgesi A; Rossi G; Tessa M; Monetti U; Ricardi U; Angelsio S; Ragona R
Radiother Oncol; 1990; 18 Suppl 1():146-50. PubMed ID: 2247642
[TBL] [Abstract][Full Text] [Related]
5. High-dose cyclophosphamide, carmustine, and etoposide followed by allogeneic bone marrow transplantation in patients with lymphoid malignancies who had received prior dose-limiting radiation therapy.
Demirer T; Weaver CH; Buckner CD; Petersen FB; Bensinger WI; Sanders J; Clift RA; Lilleby K; Anasetti C; Martin P
J Clin Oncol; 1995 Mar; 13(3):596-602. PubMed ID: 7884421
[TBL] [Abstract][Full Text] [Related]
6. High dose melphalan and total body irradiation with autologous marrow rescue in childhood acute lymphoblastic leukaemia after relapse.
Schroeder H; Pinkerton CR; Powles RL; Meller ST; Tait D; Milan S; McElwain TJ
Bone Marrow Transplant; 1991 Jan; 7(1):11-5. PubMed ID: 2043872
[TBL] [Abstract][Full Text] [Related]
7. Allogeneic marrow transplantation following cyclophosphamide and escalating doses of hyperfractionated total body irradiation in patients with advanced lymphoid malignancies: a Phase I/II trial.
Demirer T; Petersen FB; Appelbaum FR; Barnett TA; Sanders J; Deeg HJ; Storb R; Doney K; Bensinger WI; Shannon-Dorcy K
Int J Radiat Oncol Biol Phys; 1995 Jul; 32(4):1103-9. PubMed ID: 7607931
[TBL] [Abstract][Full Text] [Related]
8. Clinical and physical aspects of total body irradiation for bone marrow transplantation in Nijmegen.
Hoogenhout J; Brouwer WF; van Gasteren JJ; Schattenberg A; de Witte T; van Daal WA; Haanen CA
Radiother Oncol; 1990; 18 Suppl 1():118-20. PubMed ID: 2247634
[TBL] [Abstract][Full Text] [Related]
9. Phase I study of escalating doses of low-dose-rate, locoregional irradiation preceding Cytoxan-TBI for patients with chemotherapy-resistant non-Hodgkin's or Hodgkin's lymphoma.
Song DY; Jones RJ; Welsh JS; Haulk TL; Korman LT; Noga S; Goodman S; Herman M; Mann R; Marcellus D; Vogelsang G; Ambinder RF; Abrams RA
Int J Radiat Oncol Biol Phys; 2003 Sep; 57(1):166-71. PubMed ID: 12909229
[TBL] [Abstract][Full Text] [Related]
10. The TAM regimen prior to allogeneic and autologous bone marrow transplantation for high-risk acute lymphoblastic leukemias: a cooperative study of 62 patients.
Cahn JY; Bordigoni P; Souillet G; Pico JL; Plouvier E; Reiffers J; Benz-Lemoine E; Bergerat JP; Lutz P; Colombat P
Bone Marrow Transplant; 1991 Jan; 7(1):1-4. PubMed ID: 2043871
[TBL] [Abstract][Full Text] [Related]
11. An Italian study comparing allogeneic and autologous BMT in childhood acute lymphoblastic leukemia using HD-vincristine, F-TBI and cyclophosphamide.
Uderzo C; Colleselli P; Dini G; Bonetti F; Andolina F; Bagnulo S; Miniero R; Rondelli R; Balduzzi A; Locasciulli A
Bone Marrow Transplant; 1991; 7 Suppl 3():19-21. PubMed ID: 1855081
[No Abstract] [Full Text] [Related]
12. High-dose melphalan allows durable engraftment of allogeneic bone marrow.
van Besien K; Demuynck H; Lemaistre CF; Bogaerts MA; Champlin R
Bone Marrow Transplant; 1995 Feb; 15(2):321-3. PubMed ID: 7773226
[TBL] [Abstract][Full Text] [Related]
13. Total body irradiation-high-dose cytosine arabinoside and melphalan followed by allogeneic bone marrow transplantation from HLA-identical siblings in the treatment of children with acute lymphoblastic leukaemia after relapse while receiving chemotherapy: a Société Française de Greffe de Moelle study.
Bordigoni P; Esperou H; Souillet G; Pico J; Michel G; Lacour B; Reiffers J; Sadoun A; Rohrlich P; Jouet JP; Milpied N; Lutz P; Plouvier E; Cornu G; Vannier JP; Gandemer V; Rubie H; Gratecos N; Leverger G; Stephan JL; Boutard P; Vernant JP
Br J Haematol; 1998 Aug; 102(3):656-65. PubMed ID: 9722290
[TBL] [Abstract][Full Text] [Related]
14. Extramedullary relapse following total marrow and lymphoid irradiation in patients undergoing allogeneic hematopoietic cell transplantation.
Kim JH; Stein A; Tsai N; Schultheiss TE; Palmer J; Liu A; Rosenthal J; Forman SJ; Wong JY
Int J Radiat Oncol Biol Phys; 2014 May; 89(1):75-81. PubMed ID: 24725691
[TBL] [Abstract][Full Text] [Related]
15. Interstitial pneumonitis following autologous bone-marrow transplantation conditioned with cyclophosphamide and total-body irradiation.
Ozsahin M; Belkacémi Y; Pène F; Laporte J; Rio B; Leblond V; Korbas D; Touboul E; Gorin NC; Schlienger M; Laugier A
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(1):71-7. PubMed ID: 12118567
[TBL] [Abstract][Full Text] [Related]
16. Melphalan-total body irradiation and autologous bone marrow transplantation for adult acute leukemia beyond first remission.
Mehta J; Powles R; Singhal S; Horton C; Tait D; Treleaven J
Bone Marrow Transplant; 1996 Jul; 18(1):119-23. PubMed ID: 8832004
[TBL] [Abstract][Full Text] [Related]
17. Busulphan, cyclophosphamide, and melphalan as conditioning therapy in allogeneic bone marrow transplants for acute lymphoblastic leukemia.
Russell S; Vowels M
Transplant Proc; 1992 Feb; 24(1):183. PubMed ID: 1539236
[No Abstract] [Full Text] [Related]
18. Fractionated total body irradiation and allogeneic bone marrow transplantation for standard risk leukemia.
Altschuler C; Resbeut M; Maraninchi D; Guillet JP; Blaise D; Stoppa AM; Carcassonne Y
Radiother Oncol; 1989 Dec; 16(4):289-95. PubMed ID: 2694233
[TBL] [Abstract][Full Text] [Related]
19. Autologous peripheral blood stem cell transplantation after high dose therapy in patients with advanced lymphomas.
Brice P; Marolleau JP; Dombret H; Lepage E; Baruchel A; Adam M; Miclea JM; Sitthy X; Gisselbrecht C
Bone Marrow Transplant; 1992 May; 9(5):337-42. PubMed ID: 1352162
[TBL] [Abstract][Full Text] [Related]
20. Feasibility and efficacy of maintenance chemotherapy following autologous bone marrow transplantation for first remission acute lymphoblastic leukaemia.
Tiley C; Powles R; Treleaven J; Catovsky D; Milan S; Teo CP; Catalano J; Mehta J; Shields M; Gupta P
Bone Marrow Transplant; 1993 Nov; 12(5):449-55. PubMed ID: 8298555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
